arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

IRONWOOD PHARMACEUTICALS INC

IRWD
$4.04 ▲ +0.25 (+6.60%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
68 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
65
Health
Fair
Bullish
auto_awesome

Analytical Summary

IRONWOOD PHARMACEUTICALS INC shows strong fundamentals with top-quartile Operating Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $664.2M
Dividend Yield —
Revenue Growth 32.6% ↘
Op. Margin 70.2% ↗
ROIC -34.1% ↘
FCF / Share $0.35 ↗
Trailing P/E 13.0x
Price / Book —
FCF Yield 8.8%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$113.04M
↑ +32.6% —
Net Income Profit after all expenses
$51.29M
↑ +117.3% —
Operating Margin Operating profit as % of sales
70.2%
↑ +3.0% 89th
FCF / Share Free cash flow per share
$0.35
↑ +1031.4% —
Long-Term Debt Long-term obligations
$199.51M
— +0.1% —
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↓
82
Returns
35
Financial Health ↓
67
Cash Quality ↑
95

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 68 quarters